Boom in weight-loss drugs could lead to fall in beer sales, Heineken warns UK pubs

World's second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol

Business live - latest updates

Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.

The world's second-largest brewer sent a presentation to British hospitality customers earlier this month that said the use of GLP-1 medication - such as Ozempic and Wegovy - could reduce the desire to drink alcohol. This in turn could result in fullness and fewer serves" of pints in pubs and bars, it added.